Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.
Wagner-Drouet E, Teschner D, Wolschke C, Janson D, Schäfer-Eckart K, Gärtner J, Mielke S, Schreder M, Kobbe G, Kondakci M, Hilgendorf I, von Lilienfeld-Toal M, Klein S, Heidenreich D, Kreil S, Verbeek M, Grass S, Ditschkowski M, Gromke T, Koch M, Lindemann M, Hünig T, Schmidt T, Rascle A, Guldan H, Barabas S, Deml L, Wagner R, Wolff D. Wagner-Drouet E, et al. Among authors: janson d. Haematologica. 2021 Feb 1;106(2):363-374. doi: 10.3324/haematol.2019.229252. Haematologica. 2021. PMID: 31879324 Free PMC article.
Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level.
Modemann F, Ayuk F, Wolschke C, Christopeit M, Janson D, von Pein UM, Kröger N. Modemann F, et al. Among authors: janson d. Bone Marrow Transplant. 2020 Dec;55(12):2286-2293. doi: 10.1038/s41409-020-0952-z. Epub 2020 May 23. Bone Marrow Transplant. 2020. PMID: 32447349 Free PMC article.
Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive Status in Patients with Acute Myelogenous Leukemia.
Klyuchnikov E, Badbaran A, Massoud R, Fritsche-Friedland U, Janson D, Ayuk F, Wolschke C, Bacher U, Kröger N. Klyuchnikov E, et al. Among authors: janson d. Transplant Cell Ther. 2021 Oct;27(10):841-850. doi: 10.1016/j.jtct.2021.06.003. Epub 2021 Jun 9. Transplant Cell Ther. 2021. PMID: 34118468 Free article.
Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML.
Niederwieser C, Morozova E, Zubarovskaya L, Zabelina T, Klyuchnikov E, Janson D, Wolschke C, Christopeit M, Ayuk F, Moiseev I, Afanasyev BV, Kröger N. Niederwieser C, et al. Among authors: janson d. Bone Marrow Transplant. 2021 Nov;56(11):2834-2841. doi: 10.1038/s41409-021-01410-x. Epub 2021 Jul 30. Bone Marrow Transplant. 2021. PMID: 34331022 Free PMC article.
Correction: Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level.
Modemann F, Ayuk F, Wolschke C, Christopeit M, Janson D, von Pein UM, Kröger N. Modemann F, et al. Among authors: janson d. Bone Marrow Transplant. 2021 Oct;56(10):2617. doi: 10.1038/s41409-021-01425-4. Bone Marrow Transplant. 2021. PMID: 34413473 Free PMC article. No abstract available.
Post-Transplantation Multicolored Flow Cytometry-Minimal Residual Disease Status on Day 100 Predicts Outcomes for Patients With Refractory Acute Myeloid Leukemia.
Klyuchnikov E, Badbaran A, Massoud R, Fritsche-Friedland U, Janson D, Ayuk F, Christopeit M, Wolschke C, Bacher U, Kröger N. Klyuchnikov E, et al. Among authors: janson d. Transplant Cell Ther. 2022 May;28(5):267.e1-267.e7. doi: 10.1016/j.jtct.2022.01.014. Epub 2022 Jan 20. Transplant Cell Ther. 2022. PMID: 35066212 Free article.
50 results